Literature DB >> 20533522

Metastatic alveolar rhabdomyosarcoma in multiple endocrine neoplasia type 2A.

Ashley E Jones1, Edythe A Albano, Mark A Lovell, Stephen P Hunger.   

Abstract

Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma, accounts for 3% of childhood malignancies. Multiple Endocrine Neoplasia (MEN) type 2A is an autosomal dominant syndrome associated with near universal development of medullary thyroid carcinoma. We describe a previously unreported association of MEN-2A with metastatic alveolar RMS and review the literature on associated hereditary cancer predisposition syndromes and current therapeutic options. The high penetrance of malignancy in patients with MEN warrants a heightened suspicion for the development of nonendocrine malignancies. The diagnosis of RMS should prompt consideration of screening for familial genetic syndromes in certain patients.

Entities:  

Mesh:

Year:  2010        PMID: 20533522     DOI: 10.1002/pbc.22591

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

Review 1.  Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas.

Authors:  Anish Ray; Winston W Huh
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

2.  Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma.

Authors:  Noah E Berlow; Kenneth A Crawford; Carol J Bult; Christopher Noakes; Ido Sloma; Erin R Rudzinski; Charles Keller
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.